Smart Biosensing Technologies for Early Detection of Metabolic Disorders

AvKanwal Rehman,Muhammad Sajid Hamid Akash

Häftad, Engelska, 2026

1 992 kr

Kommande

Beskrivning

Smart Biosensing Technologies for Early Detection of Metabolic Disorders gives a clear overview of the latest biosensor tools that help detect and monitor metabolic diseases like diabetes, obesity, and insulin resistance early. It explains how these sensors work using basic science and shows new wearable, non-invasive, and easy-to-use devices. This book is useful for researchers, doctors, and professionals working in healthcare technology. This book connects research from different fields to help solve real problems in making and using biosensors. It includes examples of how these sensors are used, new markers for disease detection, and how AI and digital health can improve care. Readers will learn how to develop better diagnostic tools and improve treatment for metabolic diseases.

Provides comprehensive coverage of smart biosensing technologies for metabolic disorders, emphasizing biophysical mechanisms and disease-specific applications
Includes translational case studies and practical guidance on clinical validation, regulatory challenges, and commercialization pathways
Highlights emerging biomarkers, AI-enabled biosensors, and digital health integration for personalized metabolic healthcare
Bridges multidisciplinary perspectives from biomedical sciences, engineering, and pharmaceutical innovation to support real-world impact

Produktinformation

Utgivningsdatum:2026-09-30
Mått:191 x 235 x undefined mm
Format:Häftad
Språk:Engelska
Antal sidor:400
Förlag:Elsevier Science
ISBN:9780443459115

Utforska kategorier

Fysiologi inom Medicin
Endokrinologi inom Medicin
Tillämpad fysik inom Naturvetenskap och teknik

Mer om författaren

Dr. Kanwal Rehman is working as an Associate Professor at the Department of Pharmacy in The Women University, Multan, Pakistan. Dr. Rehman received her PhD in Pharmacology from Zhejiang University, China. She nurturesa keen interest in the pathogenesis of metabolic disorders and new therapeutic modalities for its treatment. Currently, sheis focusing on the investigation of the role of pharmacogenomics based upon gene polymorphism on various molecular andmetabolic pathways that are involved in mitogenic disorders and treatment strategies, like natural biogenic compounds against different risk factors of metabolic disorders, including pancreatitis, cardiometabolic disorders, and hormonal imbalance. Dr. Rehman has also been awarded the Research Productivity Award by the Pakistan Council for Science and Technology, Pakistan; the PAS Gold Medal from the Pakistan Academy of Sciences; and the A.R. Shakoori Gold Medal from the Zoological Society of Pakistan. Dr. Akash is currently working as an Associate Professor at the Department of Pharmaceutical Chemistry, Government College University Faisalabad, Pakistan. He got his PhD degree in Pharmaceutical Analysis from Zhejiang University, China. Currently, he is focusing on investigating the effect of endocrine disruptingchemicals on various molecular and metabolic pathways that are involved in metabolic disorders and their treatment strategies. His research work is cutting-edge and worthy of extension in developing countries, like Pakistan, where it can be most beneficial and cost-effective, especially for diabetic patients. Based on his significant scientific contributions inthe field of Pharmaceutical Sciences, he has been awarded “Research Productivity Awards from the Pakistan Council for Science and Technology, the PAS Gold Medal from the Pakistan Academy of Sciences, and the A.R. Shakoori Gold Medal from the Zoological Society of Pakistan.

Innehållsförteckning

Section I: Foundations of Biosensing and Metabolic Disorders1. Introduction to Metabolic Disorders and Diagnostic Needs2. Biomarkers of Metabolic Disorders: Molecular, Genetic, Proteomic, and Biophysical Insights3. Principles and Platforms of Biosensing Technologies: Physical, Molecular and Biophysical Detection MechanismsSection II: Emerging Biosensing Platforms for Biomarker Detection4. Nanomaterial-Based Biosensors: Sensitivity, Selectivity, and Nano-Biophysical Interactions5. Microfluidic, Lab-on-a-Chip, and Paper-Based Devices for Point-of-Care Diagnostics6. Optical, Electrochemical, and Wearable Biosensors for Metabolic Health MonitoringSection III: Smart and Intelligent Biosensing Approaches7. Artificial Intelligence and Machine Learning in Biosensing Data Analytics8. Internet of Medical Things (IoMT) and Cloud-Connected Biosensors9. Smart Wearables and Implantable Biosensors for Continuous MonitoringSection IV: Applications in Early Detection of Specific Metabolic Disorders10. Biosensing Approaches for Diabetes and Its Complications11. Smart Biosensors for Obesity and Metabolic Syndrome Detection12. Biosensing Strategies for Cardiometabolic Biomarkers13. Biomarker Detection for Rare and Inherited Metabolic Disorders14. Monitoring Oxidative Stress and Inflammation in Metabolic Disorders: Biosensing and Biophysical MethodsSection V: Translational Perspectives and Future Directions15. Regulatory, Ethical, and Commercialization Challenges in Smart Biosensing